Chiral Beta Agonist - Sepracor

• Validates non-CFC technology

• Joint development agreement for asthma drugs

• Formulate, develop, scale-up and supply clinical materials

• Receive milestones / royalties on sales

• Development on track

Previous slide

Next slide

Back to first slide

View graphic version